A DIFFERENTIATED APPROACH TO HEALTHCARE
Aisling Capital is a leading investment firm that invests in products,
technologies, and global businesses that advance health.
Since 2000, Aisling Capital has raised over $1.8 billion in committed capital across four funds. Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures. The Aisling Capital team’s combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry.